Urinary concentrations and antibacterial activity of bal30072, a novel siderophore monosulfactam, against uropathogens after intravenous administration in healthy subjects

Antimicrobial Agents and Chemotherapy

Volumn 60, Issue 6, 2016, Pages 3309-3315

  Straubinger, Marion ^a   Blenk, Holger ^a   Naber, Kurt G ^a,b   Wagenlehner, Florian M E ^c  

^a Prokaryon Institute   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^c JUSTUS LIEBIG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BAL 30072; CEFEPIME; CEFOTAXIME; CEFOXITIN; CEFTAZIDIME; IRON; SIDEROPHORE; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT; MONOBACTAM DERIVATIVE; THIAZOLE DERIVATIVE;

ADULT; ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL GROWTH; BACTERICIDAL ACTIVITY; COHORT ANALYSIS; CONTROLLED STUDY; DRUG EFFICACY; DRUG URINE LEVEL; ENTEROBACTERIACEAE; ESCHERICHIA COLI; HUMAN; HUMAN EXPERIMENT; KLEBSIELLA PNEUMONIAE; LIQUID CHROMATOGRAPHY; MALE; MINIMUM BACTERICIDAL CONCENTRATION; MINIMUM INHIBITORY CONCENTRATION; NORMAL HUMAN; PRIORITY JOURNAL; PROTEUS MIRABILIS; PSEUDOMONAS AERUGINOSA; TANDEM MASS SPECTROMETRY; URINALYSIS; URINARY EXCRETION; URINARY TRACT INFECTION; URINE VOLUME; CLINICAL TRIAL; DRUG EFFECTS; INTRAVENOUS DRUG ADMINISTRATION; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MIDDLE AGED; PATHOGENICITY; URINARY TRACT INFECTIONS; URINE;

ADMINISTRATION, INTRAVENOUS; ADULT; ANTI-BACTERIAL AGENTS; CHROMATOGRAPHY, LIQUID; ENTEROBACTERIACEAE; ESCHERICHIA COLI; HEALTHY VOLUNTEERS; HUMANS; KLEBSIELLA PNEUMONIAE; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; MONOBACTAMS; PROTEUS MIRABILIS; TANDEM MASS SPECTROMETRY; THIAZOLES; URINARY TRACT INFECTIONS;

EID: 84973641976     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.02425-15     Document Type: Article

References (19)

1. Grabe M, Bartoletti R, Bjerklund-Johansen TE, Cai T, Çek M, Köves B, Naber KG, Pickard RS, Tenke P, Wagenlehner F, Wullt B. 2015. Guidelines on urological infections. European Association of Urology, Arnhem, The Netherlands. http://uroweb.org/guideline/urological -infections/. Accessed 8 July 2015.
2. Zowawi HM, Harris PNA, Roberts MJ, Tambyah PA, Schembri MA, Pezzani MD, Williamson DA, Paterson DL. 2015. The emerging threat of multidrug-resistant Gram-negative bacteria in urology. Nat Rev Urol 12:570 -584. http://dx.doi.org/10.1038/nrurol.2015.199.
3. Van Delden C, Page MGP, Köhler T. 2013. Involvement of Fe uptake systems and AmpC ô-lactamase in susceptibility to the siderophore monosulfactam BAL30072 in Pseudomonas aeruginosa. Antimicrob Agents Chemother 57:2095-2102. http://dx.doi.org/10.1128/AAC.02474-12.
4. Page MGP, Dantier C, Desarbre E. 2010. In vitro properties of BAL30072, a novel siderophore sulfactam with activity against multiresistant Gramnegative bacilli. Antimicrob Agents Chemother 54:2291-2302. http://dx .doi.org/10.1128/AAC.01525-09.
5. Page MGP, Dantier C, Desarbre E, Gaucher B, Gebhardt K, Schmitt-Hoffmann A. 2011. In vitro and in vivo properties of BAL30376, a ô-lactam and dual ô-lactamase inhibitor combination with enhanced activity against Gram-negative bacilli that express multiple ô-lactamases. Antimicrob Agents Chemother 55:1510 -1519. http://dx.doi.org/10.1128/AAC .01370-10.
6. Mushtaq S, Warner M, Livermore D. 2010. Activity of the siderophore monobactam BAL30072 against multiresistant non-fermenters. J Antimicrob Chemother 65:266 -270. http://dx.doi.org/10.1093/jac/dkp425.
7. Denome SA, Elf PK, Henderson TA, Nelson DE, Young KD. 1999. Escherichia coli mutants lacking all possible combinations of eight penicillin binding proteins: viability, characteristics, and implications for peptidoglycan synthesis. J Bacteriol 81:3981-3993.
8. Wagenlehner FME, Wagenlehner C, Redman R, Weidner W, Naber KG. 2009. Urinary bactericidal activity of doripenem versus levofloxacin in patients with complicated urinary tract infections or pyelonephritis. Antimicrob Agents Chemother 53:1567-1573. http://dx.doi.org/10.1128 /AAC.01133-08.
9. Schmitt-Hoffmann A, Roos B, Maares J, Sauer J, Spickermann J, Meyer I, Kaufhold A. 2011. Abstr 51st Intersci Conf Antimicrob Agents Chemother, poster A2-572.
10. Wagenlehner FME, Blenk B, Straubinger M, Wagenlehner CM, Blenk H, Naber KG. 2012. Urinary antibacterial activity of BAL30072 against uropathogens after IV administration in healthy volunteers, poster A-1285. Abstr 52nd Annu Intersci Conf Antimicrob Agents Chemother, San Francisco, CA, 9 to 12 September 2012.
11. Wagenlehner FME, Blenk B, Straubinger M, Wagenlehner CM, Blenk H, Naber KG. 2014. Urinary concentrations and antibacterial activity of BAL30072 against uropathogens after IV infusion in healthy volunteers, poster F-1565. Abstr 54th Annu Intersci Conf Antimicrob Agents Chemother, Washington, DC, 6 to 10 September 2014.
12. U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research, Center for Veterinary Medicine 2001. Guidance for industry: bioanalytical method validation. FDA, Silver Spring, MD. http://www.fda.gov/downloads /Drugs/Guidances/ucm070107.pdf.
13. European Medicines Agency. 2011. Guideline on bioanalytical method validation. Report EMEA/CHMP/EWP/192217/2009. European Medicines Agency, London, UK. http://www.ema.europa.eu/docs/en-GB /document-library/Scientific-guideline/2011/08/WC500109686.pdf.
14. Goodwin J, Murphy B, Guillemette M. 1966. Direct measurement of serum iron and binding capacity. Clin Chem 12:47-57.
15. Thomas L. 2012. Laboratory and diagnosis, 8th ed. TH-Books, Frankfurt, Germany.
16. Wagenlehner FME, Wagenlehner CM, Blenk B, Blenk H, Schubert S, Dalhoff A, Naber KG. 2011. Urinary pharmacokinetics and bactericidal activity of finafloxacin (200 and 800 mg) in healthy volunteers receiving a single oral dose. Chemotherapy 57:97-107. http://dx.doi.org/10.1159 /000321028.
17. Heil W, Ehrhardt V. 2008. Reference ranges for adults and children, 9th ed. Roche Diagnostics GmbH, Mannheim, Germany. https://www .rochediagnostics.fr/htdocs/media/pdf/actualites/2a-reference -ranges-2008.pdf.
18. Rabsch W, Winkelmann G. 1991. The specificity of bacterial siderophore receptors probed by bioassays. Biol Met 4:244 -250. http://dx.doi.org/10 .1007/BF01141188.
19. Tomaras AP, Crandon JL, McPherson CJ, Banevicius MA, Finegan SM, Irvine RL, Brown MF, O'Donnell JP, Nicolau DP. 2013. Adaptationbased resistance to siderophore-conjugated antibacterial agents by Pseudomonas aeruginosa. Antimicrob Agents Chemother 57:4197-4207. http: //dx.doi.org/10.1128/AAC.00629-13.